Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
Acta Histochem ; 116(1): 252-7, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23981244

ABSTRACT

Bradykinin preconditioning has been used for acquisition of tolerance after spinal cord ischemia. Rabbits were preconditioned intraperitoneally with bradykinin 48 h prior to 20 min of abdominal aorta ligation followed by 24 and 48 h of reperfusion. The activities of SOD and catalase were measured and Fluoro Jade B (FJB)-positive degenerated neurons were evaluated. The outcomes of Tarlov scoring system used to assess neurological functions showed significant improvement in bradykinin groups compared to the ischemic group. The number of FJB-positive degenerated neurons was decreased in ventral horns of both bradykinin groups. Significantly decreased activities of total SOD and mitochondrial Mn-SOD were also detected in both bradykinin groups versus ischemic group while CuZn-SOD and catalase activities were significantly decreased only in the bradykinin group after 24h of reperfusion versus ischemic group. These findings suggest that one of the possibilities of the neuroprotective effect of delayed bradykinin preconditioning against spinal cord ischemic injury could be realized by mitochondrial protection and decreased synthesis of Mn-SOD as well as by promotion of neuronal survival.


Subject(s)
Bradykinin/pharmacology , Ischemia/pathology , Neuroprotective Agents/pharmacology , Spinal Cord/blood supply , Animals , Antioxidants/metabolism , Catalase/metabolism , Ischemia/drug therapy , Ischemia/enzymology , Ischemic Preconditioning , Male , Nerve Degeneration/enzymology , Nerve Degeneration/prevention & control , Neurons/drug effects , Neurons/metabolism , Rabbits , Spinal Cord/drug effects , Spinal Cord/enzymology , Superoxide Dismutase/metabolism
2.
Clinics ; 67(8): 923-929, Aug. 2012. ilus, graf, tab
Article in English | LILACS | ID: lil-647797

ABSTRACT

OBJECTIVE: Ischemic preconditioning and some drugs can protect tissues from injury by preserving microcirculation. This study evaluated vascular permeability in a hamster cheek pouch preparation using either short ischemic periods or bradykinin as preconditioning stimuli followed by 30 min of ischemia/reperfusion. METHOD: Sixty-six male hamsters were divided into 11 groups: five combinations of different ischemic frequencies and durations (one, three or five shorts periods of ischemia, separated by one or five minutes) with 10 min intervals between the ischemic periods, followed by 30 min ischemia/reperfusion; three or five 1 min ischemic periods with 10 min intervals between them followed by the topical application of histamine (2 µM); bradykinin (400 nM) followed by 30 min of ischemia/reperfusion; and three control groups (30 min of ischemia/reperfusion or histamine or bradykinin by themselves). Macromolecular permeability was assessed by injection of fluorescein-labeled dextran (FITC-dextran, MW= 150 kDa; 250 mg/Kg body weight), and the number of leaks/cm2 was counted using an intravital microscope and fluorescent light in the cheek pouch. RESULTS: Plasma leakage (number of leaks/cm²) was significantly reduced by preconditioning with three and five 1 min ischemic periods, one and three 5 min ischemic periods and by bradykinin. Histamine-induced macromolecular permeability was also reduced after three periods of 5 min of ischemia. CONCLUSION: Short ischemic periods and bradykinin can function as preconditioning stimuli of the ischemia/reperfusion response in the hamster cheek pouch microcirculation. Short ischemic periods also reduced histamineinduced macromolecular permeability.


Subject(s)
Animals , Cricetinae , Male , Capillary Permeability/drug effects , Ischemic Preconditioning/methods , Reperfusion Injury/drug therapy , Bradykinin/pharmacology , Cheek/blood supply , Disease Models, Animal , Histamine Agonists/pharmacology , Histamine/pharmacology , Microcirculation , Plasma/drug effects , Plasma/physiology , Reperfusion Injury/blood , Time Factors , Treatment Outcome , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...